Delirium — a form of acute brain failure — affects 8-17% of older adults who present to the emergency department (ED). It is associated with adverse outcomes including higher health care use, accelerated functional decline, and increased mortality.
In 1973, the Vanderbilt DRTC began its mission to facilitate the discovery, application and translation of scientific knowledge to improve the lives of people with diabetes.
Update on Shed-MEDS, the largest geriatric deprescribing intervention trial to date.
Vanderbilt University Medical Center, Meharry Medical College and the University of Miami Miller School of Medicine are the recipients of a $12.4 million grant from the National Institutes of Health to jointly develop the Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities.
Systems-wide updates aid in implementation of the 4Ms, a framework for providing high-quality care for older patients.
Vanderbilt is providing feedback to assess how well MIPS measures are meeting goals for geriatric patients.
Fewer Black, Hispanic and Asian patients meet biomarker qualifications for landmark treatments that may slow the progression of Alzheimer’s disease by targeting amyloid plaques, according to new findings published in JAMA Neurology.
Education regarding naloxone, buprenorphine-naloxone among the strategies in new initiative.
Data from the pilot curriculum evaluation in this paper was previously presented at the American Geriatrics Society (AGS) 2021 Virtual Annual Scientific Meeting in a poster entitled “Targeted Virtual Opioid Overdose Education and Naloxone Distribution in Overdose Hotspots for Older Adults” and the final curriculum and evaluation data was presented at the American Geriatrics Society (AGS) 2022 Annual Scientific meeting as a poster and an education workshop entitled “Using virtual format and mail-delivered naloxone in a pandemic-adapted opioid training for aging services providers.”
